WinQure CEO to Speak at CGTP Europe 2026 in Lisbon

WinQure Medicine’s CEO, Dr. Stephanie Manton, will speak at the Cell & Gene Therapy Products (CGTP) Europe 2026 conference in Lisbon this October, hosted by CASSS – Sharing Science Solutions.

Dr. Manton will be joining the session, “Individualized Cell and Gene Therapies: Navigating the Path Toward Personalized Medicines,” to discuss how WinQure moves genetic therapies beyond exceptional cases and towards scalable treatment models that enable broader patient access.

If you’re attending CGTP Europe, we look forward to connecting.